141 related articles for article (PubMed ID: 17474424)
21. [Comparative genomic hybridization. Methodologic features].
García JL; Gutiérrez NC; Hernández JM; Sánchez MA; González MB; Arroyo JL; San Miguel JF
Sangre (Barc); 1999 Aug; 44(4):291-6. PubMed ID: 10589281
[No Abstract] [Full Text] [Related]
22. Recent publications in hematological oncology.
Hematol Oncol; 2001 Sep; 19(3):121-8. PubMed ID: 11574933
[No Abstract] [Full Text] [Related]
23. [Detection of abnormal numbers of chromosome 8 with interphase fluorescence in situ hybridization in hematologic malignancies].
Wang HP; Li GX; Qiao ZH; Wang HW
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):395-7. PubMed ID: 15300644
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of del(20q) in patients with hematological malignancies.
Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K
Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278
[TBL] [Abstract][Full Text] [Related]
25. [Hematologic malignancies/pediatric malignancy].
Usui N
Gan To Kagaku Ryoho; 2013 May; 40(5):582. PubMed ID: 23957064
[No Abstract] [Full Text] [Related]
26. Multicolor FISH.
Jalal SM; Law ME
Methods Mol Biol; 2002; 204():105-20. PubMed ID: 12397793
[No Abstract] [Full Text] [Related]
27. Metaphase FISH, microdissection, and multicolour FISH. Applications in haematology.
Mecucci C; Falzetti D; La Starza R
Haematologica; 1999 Jun; 84 Suppl EHA-4():98-101. PubMed ID: 10907483
[No Abstract] [Full Text] [Related]
28. Fluorescence in situ hybridization studies using BAC clones of the EVI1 locus in hematological malignancies with 3q rearrangements.
Madrigal I; Carrió A; Gómez C; Rozman M; Esteve J; Nomdedeu B; Campo E; Costa D
Cancer Genet Cytogenet; 2006 Oct; 170(2):115-20. PubMed ID: 17011981
[TBL] [Abstract][Full Text] [Related]
29. [Cytogenetic study of 121 patients suffering from various hematologic neoplasms using the in situ hybridization technique].
Pérez Losada A; Solé F; Woessner S; Florensa L; Besses C; Espinet B; Caballín MR; García Eroles L; Sans-Sabrafén J
Sangre (Barc); 1996 Jun; 41(3):201-9. PubMed ID: 8755208
[TBL] [Abstract][Full Text] [Related]
30. [DNA diagnosis in hematologic malignancies].
Sugimoto K; Oshimi K
Nihon Rinsho; 2005 Mar; 63(3):443-7. PubMed ID: 15773343
[TBL] [Abstract][Full Text] [Related]
31. Molecular cytogenetic aspects of hematological malignancies: clinical implications.
Chen Z; Sandberg AA
Am J Med Genet; 2002 Oct; 115(3):130-41. PubMed ID: 12407693
[TBL] [Abstract][Full Text] [Related]
32. Molecular cloning of a constitutional t(7;22) translocation associated with risk of hematological malignancy.
Hill AS; MacCallum PK; Young BD; Lillington DM
Genes Chromosomes Cancer; 2003 Nov; 38(3):260-4. PubMed ID: 14506701
[TBL] [Abstract][Full Text] [Related]
33. Detection of numerical aberrations in hematologic neoplasias by fluorescence in situ hybridization.
Cuneo A; Bigoni R; Roberti MG; Bardi A; Balsamo R; Piva N; Castoldi G
Haematologica; 1997; 82(1):85-90. PubMed ID: 9107092
[TBL] [Abstract][Full Text] [Related]
34. [Applications of fluorescence in situ hybridization in the study of hematologic neoplasms].
Hernández JM; Tabernero MD; García JL
Sangre (Barc); 1996 Aug; 41(4):305-9. PubMed ID: 8984672
[No Abstract] [Full Text] [Related]
35. Pattern of trisomy 1q in hematological malignancies: a single institution experience.
Djordjević V; Dencić-Fekete M; Jovanović J; Drakulić D; Stevanović M; Janković G; Gotić M
Cancer Genet Cytogenet; 2008 Oct; 186(1):12-8. PubMed ID: 18786437
[TBL] [Abstract][Full Text] [Related]
36. [Cytogenetics in the study of malignant blood diseases].
García JL; Hernández JM; Gutiérrez NC; Fernández P; Ríos A
Sangre (Barc); 1996 Aug; 41(4):289-95. PubMed ID: 8984670
[No Abstract] [Full Text] [Related]
37. Cytogenetics, in situ hybridization and molecular approaches in the diagnosis of cancer.
Glassman AB
Ann Clin Lab Sci; 1998; 28(6):324-30. PubMed ID: 9846199
[TBL] [Abstract][Full Text] [Related]
38. [Genetic methods in diagnosis of hematooncological disorders].
Macheta A; Chocholska S; Podhorecka M
Postepy Hig Med Dosw (Online); 2015 Apr; 69():475-87. PubMed ID: 25897109
[TBL] [Abstract][Full Text] [Related]
39. Marker chromosomes are a significant mechanism of high-level RUNX1 gene amplification in hematologic malignancies.
Moosavi SA; Sanchez J; Adeyinka A
Cancer Genet Cytogenet; 2009 Feb; 189(1):24-8. PubMed ID: 19167608
[TBL] [Abstract][Full Text] [Related]
40. Interphase cytogenetics of hematological neoplasms under the perspective of the novel WHO classification.
Martín-Subero JI; Gesk S; Harder L; Grote W; Siebert R
Anticancer Res; 2003; 23(2A):1139-48. PubMed ID: 12820362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
